$748 Million is the total value of Iron Triangle Partners LP's 23 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 66.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ACHC | Sell | ACADIA HEALTHCARE COMPANY IN | $40,094,519 | +8.2% | 503,447 | -1.8% | 5.36% | +0.3% |
| COO | Sell | COOPER COS INC | $28,757,250 | -9.4% | 75,000 | -11.8% | 3.84% | -16.0% |
| SGRY | Sell | SURGERY PARTNERS INC | $26,137,975 | -7.0% | 580,973 | -28.8% | 3.49% | -13.8% |
| DXCM | Sell | DEXCOM INC | $19,276,500 | -51.2% | 150,000 | -55.9% | 2.58% | -54.8% |
| MASS | Sell | 908 DEVICES INC | $6,174,000 | -31.6% | 900,000 | -14.3% | 0.82% | -36.7% |
| OLK | Sell | OLINK HLDG ABsponsored ads | $5,902,406 | -34.5% | 314,795 | -21.3% | 0.79% | -39.3% |
| STXS | Exit | STEREOTAXIS INC | $0 | – | -1,832,577 | -100.0% | -0.54% | – |
| Exit | 2SEVENTY BIO INC | $0 | – | -868,939 | -100.0% | -1.28% | – | |
| CUTR | Exit | CUTERA INC | $0 | – | -600,000 | -100.0% | -2.04% | – |
| SDGR | Exit | SCHRODINGER INC | $0 | – | -595,697 | -100.0% | -2.26% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -160,000 | -100.0% | -3.18% | – |
| LEGN | Exit | LEGEND BIOTECH CORPsponsored ads | $0 | – | -500,000 | -100.0% | -3.48% | – |
| IDXX | Exit | IDEXX LABS INC | $0 | – | -50,000 | -100.0% | -3.61% | – |
| CRL | Exit | CHARLES RIV LABS INTL INC | $0 | – | -130,000 | -100.0% | -3.78% | – |
| EVH | Exit | EVOLENT HEALTH INCcl a | $0 | – | -1,000,402 | -100.0% | -4.68% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -420,000 | -100.0% | -5.03% | – |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -80,000 | -100.0% | -5.45% | – |
| SNY | Exit | SANOFIsponsored adr | $0 | – | -1,179,736 | -100.0% | -9.26% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HORIZON THERAPEUTICS PUB LTD | 12 | Q3 2022 | 9.0% |
| GUARDANT HEALTH INC | 12 | Q3 2022 | 6.1% |
| CHARLES RIV LABS INTL INC | 11 | Q1 2023 | 7.8% |
| SURGERY PARTNERS INC | 11 | Q2 2023 | 6.4% |
| ICON PLC | 10 | Q3 2023 | 11.7% |
| BOSTON SCIENTIFIC CORP | 10 | Q3 2023 | 8.9% |
| NEVRO CORP | 10 | Q1 2022 | 6.7% |
| DEXCOM INC | 10 | Q3 2023 | 7.7% |
| ABBVIE INC | 9 | Q3 2023 | 8.1% |
| ACADIA HEALTHCARE COMPANY IN | 9 | Q3 2023 | 7.9% |
View Iron Triangle Partners LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Iron Triangle Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.